SCHEMBL9419042

SCHEMBL9419042

CC(O)c1ccc2c(c1)C(C)CCCC2(C)C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.35
RXRB P28702 2/20 0.35
NAMPT P43490 1/20 0.34
KARS1 Q15046 2/20 0.33
RARA P10276 4/20 0.33
RARB P10826 4/20 0.33
RARG P13631 4/20 0.33
UGT2B7 P16662 1/20 0.33
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
RXRG P48443 1/20 0.32
NOX1 Q9Y5S8 1/20 0.32
LMNA P02545 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP26A1 O43174 1/20 0.31
CYP26B1 Q9NR63 1/20 0.31
ACACB O00763 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9419007 0.89 RXRA (0.35) RXRARXRBKARS1RARARARB
SCHEMBL9418950 0.77 RXRA (0.51) RXRARXRBRARARARBRARG
SCHEMBL9863066 0.75 CYP2D6 (0.36) NAMPTKARS1UGT2B7LMNA
SCHEMBL3541162 0.73 RXRA (0.58) RXRARXRBRARARARBRARG
SCHEMBL8735903 0.73 KARS1 (0.40) RXRARXRBKARS1UGT2B7CCNE1
SCHEMBL9418955 0.72 KARS1 (0.42) RXRARXRBKARS1CCNE1CDK2
SCHEMBL8732926 0.71 RXRA (0.40) RXRARXRBKARS1RARARARB
SCHEMBL9419032 0.70 RXRA (0.38) RXRARXRBKARS1RARARARB
SCHEMBL11438868 0.69 HPGD (0.36) RXRARXRBKARS1CCNE1CDK2
SCHEMBL31003100 0.69 RXRA (0.40) RXRARXRBKARS1RARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0315071-B1 Benzocyclohepten derivatives, their preparation and utilisation for pharmaceutics HOFFMANN LA ROCHE (CH) 1994-07-20 EP disclosed
EP-0315071-A2 Benzocyclohepten derivatives, their preparation and utilisation for pharmaceutics F. HOFFMANN-LA ROCHE AG (CH) 1989-05-10 EP disclosed